{"id":"W2152957042","doi":"10.1093/eurheartj/eht135","title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Servier; Astellas Pharma; Regado Biosciences; Duke Clinical Research Institute; Daiichi-Sankyo; Medicines Company; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; F. Hoffmann-La Roche; GlaxoSmithKline; Amgen; Pfizer; Sanofi; Abbott Laboratories","keywords":"Medicine; Apixaban; Atrial fibrillation; Warfarin; Internal medicine; Cardiology; Duration (music); Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002893085,0.001098204,0.002830483,0.000317375,0.0002980829,0.001438792,0.0005268076,0.001168199,0.003109433],"category_scores_gemma":[0.00360154,0.0002768058,0.003523439,0.0003799629,0.0003965854,0.0007610262,0.0004710857,0.001505015,0.0003504907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000509214,"about_ca_system_score_gemma":0.0005179501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006941999,"about_ca_topic_score_gemma":0.001643782,"domain_scores_codex":[0.9985161,0.0008639314,0.0001332603,0.0001857217,0.0001753162,0.0001256097],"domain_scores_gemma":[0.997788,0.0008718448,0.0006192995,0.0002261265,0.00013284,0.0003618001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9196821,0.0007181289,0.01550384,0.003085332,0.02277079,0.0001298392,0.00008383523,0.0009868836,0.001064624,0.0004844657,0.00440259,0.03108759],"study_design_scores_gemma":[0.7639086,0.03274222,0.1495217,0.0009829547,0.04018547,0.0004813347,0.0001361258,0.002157868,0.0008356112,0.002748827,0.006146355,0.0001530774],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9300539,0.05722588,0.0007873367,0.002152113,0.000605364,0.0003229748,0.004504009,0.00008081595,0.004267597],"genre_scores_gemma":[0.9847883,0.007614299,0.0005258356,0.001425478,0.000677273,0.0004263594,0.003235829,0.00002279773,0.00128389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003109433,"threshold_uncertainty_score":0.01530033,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08043531922564112,"score_gpt":0.3264934249058093,"score_spread":0.2460581056801682,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}